How are ORKA collar max profit and max loss calculated?

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the ORKA collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 80.80%), the computed maximum profit is $452.00 per contract and the computed maximum loss is -$548.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ORKA collar?

The breakeven for the ORKA collar priced on this page is roughly $110.48 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ORKA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ORKA implied volatility affect this collar?

ORKA ATM IV is at 80.80% with IV rank near 13.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

ORKA Collar Strategy

ORKA (Oruka Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

ORKA (Oruka Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.48B, a beta of -0.39 versus the broader market, a 52-week range of 14.03-109.415, average daily share volume of 1.6M, a public-listing history dating back to 1997, approximately 68 full-time employees. These structural characteristics shape how ORKA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -0.39 indicates ORKA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ORKA pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a collar on ORKA?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

ORKA snapshot

As of August 14, 2026, spot at $109.93, ATM IV 80.80%, IV rank 13.57%, expected move 23.16%. The collar on ORKA below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this collar structure on ORKA specifically: IV regime affects collar pricing on both sides; compressed ORKA IV at 80.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 23.16% (roughly $25.46 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORKA expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORKA should anchor to the underlying notional of $109.93 per share and to the trader's directional view on ORKA stock.

ORKA collar setup

The ORKA collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORKA at $109.93 on that close, the first option leg uses a $115.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORKA chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORKA shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$109.93	long
Sell 1	Call	$115.00	$8.35
Buy 1	Put	$105.00	$8.90

ORKA collar risk and reward

Net Premium / Debit: -$11,048.00
Max Profit (per contract): $452.00
Max Loss (per contract): -$548.00
Breakeven(s): $110.48
Risk / Reward Ratio: 0.825

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

ORKA collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on ORKA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$548.00
$24.32	-77.9%	-$548.00
$48.62	-55.8%	-$548.00
$72.93	-33.7%	-$548.00
$97.23	-11.6%	-$548.00
$121.54	+10.6%	+$452.00
$145.84	+32.7%	+$452.00
$170.15	+54.8%	+$452.00
$194.45	+76.9%	+$452.00
$218.76	+99.0%	+$452.00

When traders use collar on ORKA

Collars on ORKA hedge an existing long ORKA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

ORKA thesis for this collar

The market-implied 1-standard-deviation range for ORKA extends from approximately $84.47 on the downside to $135.39 on the upside. A ORKA collar hedges an existing long ORKA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current ORKA IV rank near 13.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORKA at 80.80%. As a Healthcare name, ORKA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORKA-specific events.

ORKA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORKA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORKA alongside the broader basket even when ORKA-specific fundamentals are unchanged. Always rebuild the position from current ORKA chain quotes before placing a trade.

Frequently asked questions

What is a collar on ORKA?: A collar on ORKA is the collar strategy applied to ORKA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With ORKA stock at $109.93 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ORKA chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ORKA collar max profit and max loss calculated?: Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the ORKA collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 80.80%), the computed maximum profit is $452.00 per contract and the computed maximum loss is -$548.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ORKA collar?: The breakeven for the ORKA collar priced on this page is roughly $110.48 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ORKA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on ORKA?: Collars on ORKA hedge an existing long ORKA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current ORKA implied volatility affect this collar?: ORKA ATM IV is at 80.80% with IV rank near 13.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.